Found: 314
Select item for more details and to access through your institution.
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5147, doi. 10.3390/jcm13175147
- By:
- Publication type:
- Article
Inflammatory Bowel Disease and Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2943, doi. 10.3390/cancers16172943
- By:
- Publication type:
- Article
Small Bowel Cancer in Crohn's Disease.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2901, doi. 10.3390/cancers16162901
- By:
- Publication type:
- Article
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 8, p. 924, doi. 10.3390/cells8080924
- By:
- Publication type:
- Article
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1002629
- By:
- Publication type:
- Article
The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 533, doi. 10.1111/apt.13897
- By:
- Publication type:
- Article
Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 6, p. 477, doi. 10.1007/s40261-022-01162-6
- By:
- Publication type:
- Article
Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory Diseases.
- Published in:
- Nutrients, 2022, v. 14, n. 5, p. N.PAG, doi. 10.3390/nu14051039
- By:
- Publication type:
- Article
Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284819848631
- By:
- Publication type:
- Article
Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284819848631
- By:
- Publication type:
- Article
Preventing disability in inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 11, p. 865, doi. 10.1177/1756283X17732720
- By:
- Publication type:
- Article
Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases.
- Published in:
- Therapeutic Advances in Gastroenterology, 2015, v. 8, n. 2, p. 66, doi. 10.1177/1756283X14558193
- By:
- Publication type:
- Article
Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 4, p. 542, doi. 10.1111/joim.13503
- By:
- Publication type:
- Article
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
- Published in:
- Drugs, 2021, v. 81, n. 16, p. 1859, doi. 10.1007/s40265-021-01610-1
- By:
- Publication type:
- Article
Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Pharmacological Prevention of Postoperative Recurrence in Crohn's Disease.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 385, doi. 10.1007/s40265-020-01266-3
- By:
- Publication type:
- Article
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
- Published in:
- Drugs, 2020, v. 80, n. 2, p. 99, doi. 10.1007/s40265-020-01256-5
- By:
- Publication type:
- Article
Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study.
- Published in:
- Gastroenterology Research & Practice, 2020, p. 1, doi. 10.1155/2020/4060648
- By:
- Publication type:
- Article
PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 6, p. 1276, doi. 10.3390/ijms18061276
- By:
- Publication type:
- Article
Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries.
- Published in:
- BMC Health Services Research, 2022, v. 22, p. 1, doi. 10.1186/s12913-022-08683-y
- By:
- Publication type:
- Article
Identification of the optimal medical and surgical management for patients with perianal fistulising Crohn's disease.
- Published in:
- Colorectal Disease, 2023, v. 25, n. 1, p. 75, doi. 10.1111/codi.16314
- By:
- Publication type:
- Article
Treatment Algorithms for Crohn's Disease.
- Published in:
- Digestion, 2020, v. 101, p. 43, doi. 10.1159/000506364
- By:
- Publication type:
- Article
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
- Published in:
- Digestion, 2017, v. 96, n. 3, p. 166, doi. 10.1159/000480231
- By:
- Publication type:
- Article
Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease.
- Published in:
- Digestion, 2012, v. 86, p. 28, doi. 10.1159/000341950
- By:
- Publication type:
- Article
Mucosal Healing with Anti-TNF Antibodies.
- Published in:
- Digestion, 2012, v. 86, p. 16, doi. 10.1159/000341957
- By:
- Publication type:
- Article
Treatment of Fibrostenotic and Fistulizing Crohn's Disease.
- Published in:
- Digestion, 2012, v. 86, p. 23, doi. 10.1159/000341961
- By:
- Publication type:
- Article
Treatment of Fibrostenotic and Fistulizing Crohn's Disease.
- Published in:
- Digestion, 2012, p. 23, doi. 10.1159/000341961
- By:
- Publication type:
- Article
Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease.
- Published in:
- Digestion, 2012, p. 28, doi. 10.1159/000341950
- By:
- Publication type:
- Article
Mucosal Healing with Anti-TNF Antibodies.
- Published in:
- Digestion, 2012, p. 16, doi. 10.1159/000341957
- By:
- Publication type:
- Article
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy.
- Published in:
- Drug Design, Development & Therapy, 2022, v. 16, p. 1897, doi. 10.2147/DDDT.S340459
- By:
- Publication type:
- Article
The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 2, p. 598, doi. 10.1007/s12325-023-02673-0
- By:
- Publication type:
- Article
Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2342, doi. 10.1007/s12325-021-01990-6
- By:
- Publication type:
- Article
Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn's disease
- Published in:
- 2021
- By:
- Publication type:
- Letter
Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases.
- Published in:
- Inflammatory Intestinal Diseases, 2020, v. 5, n. 3, p. 124, doi. 10.1159/000507930
- By:
- Publication type:
- Article
Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 6, p. 1, doi. 10.1002/ctm2.455
- By:
- Publication type:
- Article
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 686, doi. 10.1111/apt.18194
- By:
- Publication type:
- Article
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 5, p. 563, doi. 10.1111/apt.18158
- By:
- Publication type:
- Article
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 175, doi. 10.1111/apt.17751
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 740, doi. 10.1111/apt.17666
- By:
- Publication type:
- Article
Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 7, p. 659, doi. 10.1111/apt.17684
- By:
- Publication type:
- Article
A randomised, double‐blind, placebo‐controlled study of the LAG‐3‐depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 3, p. 283, doi. 10.1111/apt.17557
- By:
- Publication type:
- Article
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 11, p. 1231, doi. 10.1111/apt.17509
- By:
- Publication type:
- Article
Editorial: risankizumab – ready to break ceilings? author's reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 486, doi. 10.1111/apt.17261
- By:
- Publication type:
- Article
Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 496, doi. 10.1111/apt.17242
- By:
- Publication type:
- Article